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Carbonyl reductase occurs in multiple molecular forms. Sequence analysis has yielded a carboxyethyllysine r sidue in one of the enzyme forms, 
suggesting that pyruvate has been incorporated in a posttranslational enzymatic reaction [Krook, M., Ghosh, D., Stromberg R., Carlquist, M. 
and Jiimvall, H. (1993) Proc. Natl. Acad. Sci. USA 90,502-5061. Using highly purified carbonyl reductase from human brain we show that pyruvate 
and other 2-oxocarboxylic acids are bound to the enzyme in an autocatalytic reaction. The resulting enzyme forms were indistinguishable from 
the native enzyme forms by electrophoresis and isoelectric focusing. 
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1. INTRODUCTION 
Carbonyl reductase (EC 1.1.1.184) is a cytosolic, 
monomeric oxidoreductase that catalyzes the NADPH- 
dependent reduction of a variety of quinones, ketones 
and aldehydes. It is widely distributed in human tissues, 
and enzymes with similar properties are present in other 
mammalian and nonmammalian species [11. Character- 
istically, the enzyme occurs in multiple molecular forms 
differing in apparent molecular weight and charge but 
with apparently identical enzymatic properties [2-71. 
Three forms, designated according to their isoelectric 
points as CR-8.5, CR-8 and CR-7, respectively, have 
been purified from human brain [2]. Sequence analysis 
of cDNAs isolated from human placenta, liver and 
MCF-7 breast cancer cell line cDNA libraries, respec- 
tively, revealed no heterogeneity of the corresponding 
proteins [8,9], suggesting posttranslational modification 
rather than genetic diversity to be the cause of the mul- 
tiple forms. 
The nature of the reductase was not invesitigated, but 
in view of the broad specificity of carbonyl reductase for 
aldehydes and ketones some mechanistic onnection be- 
tween enzyme actvity and enzyme modification was 
considered an intriguing possibility. In the present 
study, we used highly purified enzyme from human 
brain to verify this possibility and to investigate the 
structural basis of other molecular forms. 
2. EXPERIMENTAL 
Carbonyl reductase was purified to apparent homogeneity from 
human brain as described previously [2]. Antibodies were raised in 
rabbits and further puritied by ammonium sulfate precipitation and 
DEAE-Sephadex chromatography [l I]. Their specificity has been 
demonstrated [11,12]. Coenzymes, 2’-AMP and carbonyl compounds 
were purchased from Sigma (St. Louis, MO, USA) and Fluka (Buchs, 
Switzerland). 
Carbonyl reductase activity was determined spectrophotometrically 
at 340 nm in 80 mM sodium phosphate @H 7.0), 0.05 mM NADPH 
and 0.25 mM menadione. 
Forrest et al. first reported the occurrence of a mod- 
ified lysine residue at position 239 of carbonyl reductase 
from human placenta, although the nature of the mod- 
ification was not clarified [9]. More recently, Jornvall 
and coworkers identified an N6-( 1 -carboxyethyl)lysine 
residue at the same position and suggested that this 
compound was formed from the lysine and pyruvate via 
a Schiff base and subsequent reduction, where at least 
the second step would require enzymatic catalysis [lo]. 
Modification of carbonyl reductase was carried out under standard 
conditions in 100 mM sodium phosphate (pH 7) in the presence of 50 
PM NADPH and 10 mM carbonyl compound at 30°C for 20 h or at 
reagent concentrations and conditions as indicated in the text. 
Polyacrylamide gel electrophoresis was carried out in 12% 
acrylamide gels in the presence of 0.1% sodium dodecylsulfate accord- 
ing to Laemmli [13]. Proteins were blotted on Immobilon sheets (Mil- 
lipore, Milford, MA, USA) using a Bio-Rad electroblotting apparatus 
(Richmond, CA, USA), and the membranes were incubated with anti- 
carbonyl reductase antibodies in 50 mM Tris (pH 8.3) overnight. 
Bound antibodies were made visible using horseradish peroxidase 
coupled to protein A (Dr. Bommeli, Bern, Switzerland), H202 and 
diaminobenzidine [l11. 
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Isoelectric focusing on thin-layer polyacrylamide gels (Pharmacia, 
Uppsala, Sweden) in the pH range 3.5-9 was carried out as described 
by the manufacturer. Carbonyl reductase was detected on the basis of 
enzyme activity in the presence of NADPH, menadione and nitroblue 
tetrazolium chloride 121. 
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3. RESULTS 
3.1. Reaction with pyruvate 
Assuming the modification of Lys-239 to be the cause 
of the multiple forms [9, lo] the unmodified enzyme cor- 
responds to the most basic form, CR-8.5, and the py- 
ruvate-modified enzyme to either CR-8 or CR-7. The 
three forms are best distinguished on the basis of differ- 
ences in apparent molecular weight by sodium do- 
decylsulfate-polyacrylamide gel electrophoresis or in 
charge by isoelectric focusing [2]. Figs. 1 and 2 show 
electrophoresis and isoelectric focusing gels, respec- 
tively, of carbonyl reductase after incubation with py- 
ruvate under different conditions. In the absence of 
NADPH, pyruvate did not affect the mobility of CR- 
8.5, whereas in the presence of the coenzyme two forms, 
one corresponding to the native nzyme and the other 
exhibiting the same mobility as CR-8, were detectable. 
Treatment of the reaction mixture with borate before 
electrophoresis to dissociate Schiff bases did not alter 
the electrophoresis pattern. On the other hand, replace- 
ment of NADPH by NADP+, 2’-AMP or NADH re- 
sulted in the absence of the second form. These results 
show that NADPH is essential for enzyme modification 
in agreement with an autocatalytic reaction. To clarify 
the question whether the reaction is catalyzed by the 
same or by other enzyme molecules, carbonyl reductase 
was inactivated to various degrees by 4-OH- mercu- 
ribenzoate [2] before incubation with pyruvate and 
NADPH. As expected for an enzyme-catalyzed reac- 
tion, total loss of activity prevented the formation of the 
slower migrating form. On the other hand, a larger 
portion of the partially inactivated enzyme than the 
fraction of enzymatically active molecules was con- 
verted to CR-8 (Fig. 3A), indicating that the active mol- 
ecules catalyzed the modification inactivated molecules. 
Opposite effects were observed when the concentra- 
tion of the reaction partners, pyruvate and carbonyl 
reductase, was varied (cf. Fig. 3). Following the law of 
mass action, the proportions of the two forms changed 
in favor of CR-8 with increasing concentrations of py- 
ruvate. In contrast, increasing the concentration of the 
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Fig. 1. Sodium dodecylsulfate-polyacrylamide gelelectrophoresis of 
carbonyl reductase after incubation with 2-oxocarboxylic acids. (A) 
CR-8.5 and (B) CR-8 were incubated under standard conditions with 
the following compounds: lane 1, control CR-8.5; lane 2, pyruvate 
without NADPH; lane 3,2-oxoglutarate without NADPH; lanes 4,7, 
pyruvate plus NADPH; lanes 5,8,2-oxoglutarate plus NADPH; lane 
6, control CR-8; lane 9, control CR-7. Enzyme forms were made 
visible by immuno-staining after transfer to Immobilon membranes. 
Fig. 2. Polyacrylamide gel isoelectric focusing of carbonyl reductase 
after incubation with 2-oxocarboxylic acids. CR-8.5 was incubated 
under standard conditioy with NADPH and the following com- 
pounds: lanes l-3, contr s CR-7, CR-8, CR-8.5; lane 4, acetoacetate; 
lane 5, % 2-oxo-3-methylbtyrate; lane 6, 2-oxo-3-methylvalerate; lane 
7, 2-oxoisocaproate; lane 8,2-oxobutyrate; lane 9, pyruvate; lane 10, 
pyruvate without NADPH; lane 11,3-oxoglutarate; lane 12,2-oxoglu- 
tarate; lane 13,2-oxoadipate. The gel was stained for enzyme activity. 
enzyme decreased the portion of the modified enzyme. 
Addition of the nonionic detergent Triton X- 100 to the 
incubation mixture did not alter the proportions of the 
two forms but stabilized the enzyme at low concentra- 
tions. Virtually complete modification could thus be 
obtained at low enzyme and high pyruvate concentra- 
tions. Under no conditions, however, we observed an 
additional, third enzyme form. Similarly, no additional 
form became detectable if CR-8 from brain was incu- 
bated with pyruvate and NADPH (Fig. 1 B). These find- 
ings indicate that only one lysine residue is susceptible 
to autocatalytic modification. Other enzyme forms 
probably arise from modification of the same lysine 
residue by other ligands. Various carbonyl compounds, 
in particular 2-oxocarboxylic acids, were therefore 
tested as possible modifying agents. 
3.2. Reaction with other carbonyl compounds 
The homologues of pyruvate, 2-oxobutyrate and 2- 
oxocaproate as well as 2-oxoisocaproate yielded an en- 
zyme form which, similar to the reaction product with 
pyruvate, was indistinguishable from CR-8 by sodium 
dodecylsulfate-polyacrylamide g l electrophoresis and 
isoelectric focusing. 2-Oxo-3-methylbutyrate and 2-0x0- 
3-methylvalerate in which the carbon chain branches 
proximate to the 0x0 group gave only very faint bands 
at the position of CR-8, and acetoacetate in which the 
0x0 group is in the p-position produced no slower mi- 
grating enzyme form (Fig. 2) 
Electrophoresis patterns different from those ob- 
served with pyruvate and the other 2-oxocarboxylic 
compounds were obtained with the dicarboxylic acids 
2-oxoglutarate and 2-oxoadipate. Both compounds 
yielded an enzyme form that on both electrophoresis 
(Fig. 1) and isoelectric focusing gels (Fig. 2) migrated 
at the same position as CR-7. Similarly to the results 
obtained with pyruvate, the degree of modification by 
2-oxoglutarate was inversely related to the enzyme con- 
centration (Fig. 3B) and proportional to the concentra- 
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Fig. 3. Dependence of carbonyl reductase modification on (A) enzyme 
inactivation, (B) enzyme concentration and (C) ligand concentration, 
detected by sodium dodecyl-sulfate polyacrylamide gel electrophore- 
sis. (A) CR-8.5 was incubated with 2 and 5pM COH-mercuribenxoate 
(pMB), respectively, dialyzed against reaction buffer and incubated 
with NADPH and pyruvate under standard conditions. Lane 1, con- 
trol (100% activity); lane 2, enzyme incubated with 2 ,vM pMB (29% 
activity); lane 3, enzyme incubated with 5,uM pMB (5% activity). (B) 
CR-8.5 (120 @ml) was diluted 4- and lo-fold, respectively, before 
incubation with NADPH and 2-oxoglutarate under standard condi- 
tions. Equal amounts of protein were applied to the gel. Lane 1, 
undiluted enzyme; lane 2,4-fold diluted enzyme; lane 3, IO-fold diluted 
enzyme. (C) CR-8.5 (corresponding to the 4-fold diluted enzyme in 
panel (B) was incubated under standard conditions with NADPH and 
the following concentrations of 2-oxoglutarate: lane 1, 1 mM; lane 2, 
5 mM; lane 3, 10 mM; lane 4,20 mM. Bands on all gels were made 
visible by immunostaining. 
tion of the ligand (Fig 3C). 3-Oxoglutarate, in agree- 
ment with the result obtained with acetoacetate, did not 
affect the mobility of the enzyme. Similarly, replacing 
CR-8.5 by CR-8 prevented the formation of CR-7 by 
2-oxoglutarate (Fig. 1 B), in keeping with the hypothesis 
that both CR-8 and CR-7 arise from modification of the 
same lysine residue by different ligands. 
Multiple bands were also observed after incubation 
of the enzyme with dicarbonyl compounds, e.g. meth- 
ylglyoxal, which bind to arginine residues [14]. How- 
ever, the reaction also occurred in the absence of 
NADPH as well as in the presence of NADP’. Moreo- 
ver, all dicarbonyls completely abolished the enzyme 
activity, in contrast to the oxocarboxylic compounds 
which did not inactivate the enzyme. Sugar aldehydes 
and ketones, including glucose galactose and fructose, 
which are known to bind to proteins nonenzymatically 
had no effect on the electrophoretic mobility of the 
various carbonyl reductase forms. Moreover, carbonyl 
reductase which had been incubated with fructose or 
glucose was not retained on a phenylboronate column, 
indicating that no fructosamine had been formed. 
4. DISCUSSION 
The present results demonstrate the ability of car- 
bony1 reductase to catalyze its own modification by 
pyruvate and other 2-oxocarboxylic compounds. The 
reaction occurs between two molecules, one functioning 
as catalyst, the other as substrate, rather than within the 
same molecule, in agreement with structural data from 
computer modeling, which located the modified lysine 
residue outside of the active site cleft [lo]. The pyruvate- 
modified enzyme exhibits the same electrophoretic 
properties as CR-8 from human brain and most proba- 
bly corresponds to the carboxyethylated enzyme form 
identified by Jiirnvall and coworkers [lo]. In addition 
to pyruvate, several mono-carboxylic homologues 
yielded an enzyme form with apparently identical elec- 
trophoretic mobility, whereas the dicarboxylic com- 
pounds, 2-oxoglutarate and 2-oxoadipate, in line with 
their additional negative charge, produced a more 
acidic enzyme form with the same electrophoretic prop- 
erties as CR-7 from brain. The difference in apparent 
molecular weight between the native and modified en- 
zyme forms, about 400 and 900, respectively [2], is sig- 
nificantly larger than, and apparently independent of, 
the molecular weight of the ligands. Uncomplete un- 
folding of the modified proteins in the presence of so- 
dium dodecylsulfate and/or altered binding of the deter- 
gent may be responsible for the observed differences. 
Imino compounds, with the exception of dicbloro- 
phenol-indophenol, have not previously been reported 
as substrates of carbonyl reductase. In contrast to the 
carbonyl substrates which comprise a broad range of 
structurally different compounds, the specificity for 
imino compounds was rather restricted. A carboxyl 
group adjacent to the imino group was essential for 
enzyme activity, and a side chain at the B-position al- 
most completely prevented the modification of the en- 
zyme. Since the reduction of low molecular weight car- 
bony1 compounds does not show comparable restric- 
tions, interference with amino acid residues in the vicin- 
ity of Lys-239 may be responsible for the restricted 
specificity. Similarly, the inverse relationship between 
the enzyme concentration and the extent of modifica- 
tion suggests that protein-protein interactions either 
prevent the formation of the Schiff base or, more likely, 
impede the formation of the enzyme substrate complex 
between two carbonyl reductase molecules. 
To our knowledge, the reductive carboxyalkylation 
of lysine residues by 2-oxocarboxylic acids has not pre- 
viously been detected in other proteins. Under physio- 
logical conditions, the respective cytosolic concentra- 
tions of pyruvate and 2-oxoglutarate probably deter- 
mine the proportions of CR-8 and CR-7. However, in 
some metabolic diseases, e.g. maple syrup urine disease 
and 2-oxoadipic aciduria, other 2-oxocarboxylic acids 
may also bind significantly to the enzyme. The physio- 
logical or pathophysiological significance of the reac- 
tion, however, remains unknown. With the exception of 
small differences in the Km values for NADPH and the 
specific activities, the native and the modified enzyme 
forms exhibit the same substrate specificities and sensi- 
tivities to inhibitors [15]. However, essentially all com- 
parative studies have been carried out with small sub- 
strates which probably do not interact with Lys-239 
[IO]. In contrast, larger substrates, e.g. prostaglandins 
or steroids, might interact with the lysine residue and 
exhibit different aflinities for the three enzyme forms. 
Alternatively, the introduction of negative charges 
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might affect the interaction with other protein mole- 
cules and modulate the activity and/or stability of the 
enzyme. More information may become available with 
the detection of similar modifications in other proteins. 
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